Cushing syndrome from topical foam steroid use in an adolescent male.
Gold-von Simson
Gabrielle
G
Department of Pediatrics, New York University School of Medicine, New York, USA.
Kohn
Brenda
B
Axelrod
Felicia B
FB
D000287:Administration, Topical; D000293:Adolescent; D001774:Blood Chemical Analysis; D002990:Clobetasol / Q000009:adverse effects* / Q000627:therapeutic use; D003480:Cushing Syndrome / Q000139:chemically induced* / Q000503:physiopathology; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011379:Prognosis; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy; D035583:Rare Diseases; D018570:Risk Assessment; D012535:Scalp; D012720:Severity of Illness Index; D015430:Weight Gain
D005938:Glucocorticoids; D002990:Clobetasol